A new spectrofluorimetric technique was produced for the analysis of benidipine (BDP) in tablets and spiked plasma samples. The developed method was based on coupling between Benidipine, (a secondary amine group), and 7-fluoro-4-nitrobenzo-2-oxa-1,3-diazole (NBD-F) forming fluorescent dervatived as a NBD-Benidipine. The reaction was occured by using pH 8.5 buffer solution to form fluorescent derivatives that are measured λem: 550 nm and λex: 465 nm. A variable parameters effecting on the derivatization process were studied. The calibration graph was linear in the range of 10-200 ng mL -1 . LOD and LOQ values were a 0.445 ng mL -1 and 1.348 ng mL -1, respectivelly. The developed method was applied to BDP in commercially available film tablets. An average recovery was found as 99.80% without interference from the available excipients. Besides, the fluorimetric technique was also succesfully applied to spiked human plasma.
. INTRODUCTION
Calcium antagonist group drugs are very frequently used cardiovascular drugs 1]. (±)-(R*)-2,6-Dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid (R*)-1-benzyl-3-piperidinyl ester, methyl ester hydrochloride (benidipine hydrochloride) ( Figure 1 ) is often used as an anti anginal and antihypertensive agent. Treatment may be administered daily for hypertension at a 4 or 8 mg single dose or twice a day 2, 3]. In a study on volunteers receiving a 16 mg of oral benidipine tablet, Cmax value was found as 10.54 ± 6.02 ng mL -1 4]. Literature research has been shown in a couple of methods for determination of BDP such as spectrophotometric [5] voltammetric and HPLC [6] gas chromatographic [7] [8] [9] and LC-MS methods [10] . The purpose of the present method is to develop a novel spectrofluorimetric method based on the reaction between benidipine and 7-fluoro-4-nitrobenzo-2-oxa-1,3-diazole (NBD-F) reagent. Amines react with NBD-F reagent to perform the fluorescent products with excitation at 460-470 nm and emission at 525-530 nm [11] . The developed study is a very sensitive fluorimetric technique for the analysis of BDP in tablets and spiked plasma samples. The experimental parameters have been investigated and optimized for the efficiency of the reaction product. Each parameter has been changed separately while the other parameters were constant. These parameters are as follows; diluting solvent, volume of the buffer, pH, reaction time, concentration of NBD-F and temperature.
In order to choose optimum pH, different pH values between 7 to 11 were studied using borate buffer. pH 8.5 was choosen as optimum pH ( Figure 3 ). Before measurement, the acidification was made with 0.2 mL of 1.0 N HCl because of produce of NBD-OH (its maximum absorbance at 465 nm). 0-3 mL volumes of pH 8.5 borate buffer were trialed. 0.2 mL borate buffer addition is found to be suitable. Temperature from 60 to 80 °C range was investigated to found optimum temperature on the reaction procedure. the highest intensity obtained at 80°C ( Figure 4 ). As shown in Figure 4 , the temperature on the BDP and NBD-F reaction was examined at a range of 60 to 80°C and the highest intensity was obtained at 80°C at 3 min. The obtained colour remained stable for 12 h. The NBD-F concentration has been also invesitigated. As shown in Figure 5 , 0.2 mL of 0.5% NBD-F solution was choosen. Organic solvents, (i.e. dichloromethane, acetonitrile, methanol, chloroform and ethyl acetate) were studied. Dichloromethane gave the highest absorbance. Different solvents for selecting the most suitable one for dilution were invesitaigated such as; methanol, acetonitrile, ethanol and acetone. Methanol gave best results. The molar ratio of NBD-F to BDP was investigated based on the continuous variation method of Job [12] . The reaction stoichiometry was obtained to be 1:1 ratio using equimolar solutions of BDP and NBD-F approving that one molecule of BDP reacts with one molecule of NBD-F ( Figure 6 ). Method validation has been performed according to linearity, accuracy, precision and robustness parameters (followings ICH recommendations) [13] .
The calibration curves were plotted the relative fluorescence intensities against the drug concentrations (ng mL −1 ). The analytical parameters of the technique were presented at Table 1 . The relative fluorescence intensity values and the drug concentrations were linear within the range of 10-200 ng mL −1 . The regression equation has been shown as:
Where If is the fluorescence intensity, C is the concentration of the drug in ng mL −1 and r 2 is the coefficient of determination (n=5). The LOQ and LOD were measured following formula (according to ICH Q2 (R1) recommendation [13] , The formula has been shown as;
where Sa is the standard deviation of the intercept. LOD was 0.445 1.348 ng mL − 1 and LOQ was 1.348 ng mL − 1 . The precisions trials were performed by analysis of BDP at the three diffent concentrations (20, 100, 200 ng mL −1 ) (each n=5) for five consecutive days. The RSD values were found as 0.87%, for intra-day precision and 1.25%, inter-day precision that was indicated to high precision. (Table 1) .
The standard addition technique was used for proving accuracy of the method. The 20 ng mL −1 of sample solution were added to 10, 100, 150 ng mL −1 concentration of the standard solution and analyzed. The results of recovery study were given in Table 2 . The mean recoveries were found as 99.80%. Robustness was tested by measuring the effect of little modifications. In this research, one parameter was modified whereas the other was kept constant (time (optimum ± 1 min), temperature (optimum ± 1°C), pH (optimum ± 0.1), and HCl concentration (optimum ± 5 mM)) and the recovery percentage was measured. Obtained data proved the robustness of the proposed method.
The applicability of the proposed method was analysed by the determination of BDP in tablets. The results obtained are satisfactory with the excellent % recovery and SD<2 (Table 3 ). Experiments showed that there was no interference due to the additions and excipients. The analysis were trialed as described the general analysis procedure to understand for applicability of the proposed method to spiked plasma samples. The results were shown in Table 4 which has precise and accurate. 
CONCLUSION
The proposed fluorimetric technique has high sensitivities and simple analytical process in order to analysis of BDP in bulk, tablet formulations and spiked plasma. Therefore, the proposed technique is suggestible for a routine quality control and clinical laboratories.
MATERIALS AND METHODS

Materials
Solutions
Benidipine was kindly supplied by Pure Chem LTD (Gujarat, India) and its tablets (Coniel®) was taken from local drugstore. NBD-F and other chemicals were from Fluka. Analytical grade chemicals were used. benidipine stock solution was prepared as 1 mg mL -1 in methanol and dilution were made with the same solvent (5 g mL -1 ). Methanol was used for preparing NBD-F solution (0.5% solution). Buffer solution were prepared as follow: 0.375 g potassium chloride and 0.310 g of boric acid were weighed and 50 mL of water was added. The pH was brought to 8.0 using 0.1 N sodium hydroxide solutions.
Apparatus
Hitachi spectrofluorometer (Model U-2900) were used forf luorescence measurements Xenon lamps and 1 cm light path cells were used. The excitation wavelength was 465 nm and emission wavelength was of 550 nm. The pH was measures using the WTW pH 526 digital pH meter. (The sensitivity of the pH meter is: −2.00-16.00 pH, accuracy: 0.01 at room temperature. pH meter has been calibrated using calibration buffers have pH of 4.01, 7.00.)
Label claim a (mg/per tablet)
4.03  0.027 100.75 0.68
Methods
General procedures
0.010-0.2 mL standard series of BDP solutions has been added to 10 mL tubes. These solution has been diluted with methanol to 0.2 mL and mixed with 0.2 mL of borate solution. After addition of 0.2 mL NBD-F solution, the system was heated at 80 °C for 3 min. The cooling was done in the ice batch and then mixture was acidified using 0.2 mL of 1 N HCl solutions. The extraction was made with 5 mL of dichloromethane on a vortex mixer and centrifugated. The fluorescence intensities were measured against a blank prepared similarly (ex: 465 nm and em: 550nm). Sodium fluorescein was used as a reference standart solution.
Procedure for tablet formulation
Ten tablets were taken into 250 mL volumetric flask. After addition of 200 mL of methanol, the content was mixed 20 minutes mechanically and sonicated for 20 minutes. The volume of flask was completed to 250 mL with water. The 20 mL of the filtrate was removed. This filtrate was further diluted using methanol to get working solutions then processed as detailed under the preparation of calibration curve. The nominal contents of the tablets were determined using the calibration graph.
Procedures for plasma samples
5.0 mL of human blood sample has been used and the sample has been centrifuged at 3000 rpm for 30 min. (Ethics committee approval was taken by BVU Ethics Clinical Research Commite, number: 13/02/2019-2792). A 100 μL of plasma samples has been spiked with three different concentration (20, 100 and 200 ng mL -1) of drug and added 1 mL of 5 N NaOH followed by 1-min liquid-liquid extraction with 5 mL of diethyl ether [10] . The organic layer was evaporated through evaporated to dryness under nitrogen at room temperature. After adding 100 μl methanol to residue, method was performed according to described in Section 2. was followed and measured the fluorescence of solution (ex: 465 nm and em: 550nm). Measurement in the plasma were done a previously plotted calibration graph and using the corresponding regression equation.
